116 related articles for article (PubMed ID: 7980500)
41. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
[TBL] [Abstract][Full Text] [Related]
42. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
[TBL] [Abstract][Full Text] [Related]
43. Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling.
Yoshimura R; Araki E; Ura S; Todaka M; Tsuruzoe K; Furukawa N; Motoshima H; Yoshizato K; Kaneko K; Matsuda K; Kishikawa H; Shichiri M
Diabetes; 1997 Jun; 46(6):929-36. PubMed ID: 9166661
[TBL] [Abstract][Full Text] [Related]
44. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
45. Contraction inhibits insulin-stimulated insulin receptor substrate-1/2-associated phosphoinositide 3-kinase activity, but not protein kinase B activation or glucose uptake, in rat muscle.
Whitehead JP; Soos MA; Aslesen R; O'rahilly S; Jensen J
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):775-81. PubMed ID: 10903138
[TBL] [Abstract][Full Text] [Related]
46. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone.
Saad MJ; Folli F; Araki E; Hashimoto N; Csermely P; Kahn CR
Mol Endocrinol; 1994 May; 8(5):545-57. PubMed ID: 7520127
[TBL] [Abstract][Full Text] [Related]
47. Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
Cengel KA; Kason RE; Freund GG
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):397-404. PubMed ID: 9761740
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
He J; Usui I; Ishizuka K; Kanatani Y; Hiratani K; Iwata M; Bukhari A; Haruta T; Sasaoka T; Kobayashi M
Mol Endocrinol; 2006 Jan; 20(1):114-24. PubMed ID: 16150868
[TBL] [Abstract][Full Text] [Related]
49. Activation of the phosphatidylinositol-3' kinase pathway and DNA synthesis by a mutant insulin-like growth factor I receptor lacking the NPXY motif.
Kataoka K; Yu D; Miura M
J Endocrinol; 2004 Apr; 181(1):139-46. PubMed ID: 15072574
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells.
Saward L; Zahradka P
Circ Res; 1997 Aug; 81(2):249-57. PubMed ID: 9242186
[TBL] [Abstract][Full Text] [Related]
51. Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin.
Mendez R; Kollmorgen G; White MF; Rhoads RE
Mol Cell Biol; 1997 Sep; 17(9):5184-92. PubMed ID: 9271396
[TBL] [Abstract][Full Text] [Related]
52. Differential effects of okadaic acid on insulin-stimulated glucose and amino acid uptake and phosphatidylinositol 3-kinase activity.
Jullien D; Tanti JF; Heydrick SJ; Gautier N; Grémeaux T; Van Obberghen E; Le Marchand-Brustel Y
J Biol Chem; 1993 Jul; 268(20):15246-51. PubMed ID: 8392070
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of PI3-kinase signaling by glucocorticoids results in increased branched-chain amino acid degradation in renal epithelial cells.
Wang X; Hu J; Price SR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1874-9. PubMed ID: 17229808
[TBL] [Abstract][Full Text] [Related]
54. The p85 and p110 subunits of phosphatidylinositol 3-kinase-alpha are substrates, in vitro, for a constitutively associated protein tyrosine kinase in platelets.
Geltz NR; Augustine JA
Blood; 1998 Feb; 91(3):930-9. PubMed ID: 9446654
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms of enhanced transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.
Sasaoka T; Langlois WJ; Rose DW; Olefsky JM
J Biol Chem; 1995 May; 270(18):10885-92. PubMed ID: 7738028
[TBL] [Abstract][Full Text] [Related]
56. Nutrient modulation of cellular insulin action.
Patti ME
Ann N Y Acad Sci; 1999 Nov; 892():187-203. PubMed ID: 10842663
[TBL] [Abstract][Full Text] [Related]
57. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression.
Jhun BH; Rose DW; Seely BL; Rameh L; Cantley L; Saltiel AR; Olefsky JM
Mol Cell Biol; 1994 Nov; 14(11):7466-75. PubMed ID: 7935461
[TBL] [Abstract][Full Text] [Related]
58. Rescue and activation of a binding-deficient insulin receptor. Evidence for intermolecular transphosphorylation.
Taouis M; Levy-Toledano R; Roach P; Taylor SI; Gorden P
J Biol Chem; 1994 Nov; 269(44):27762-6. PubMed ID: 7525562
[TBL] [Abstract][Full Text] [Related]
59. The role of phosphatidylinositol-3 kinase in vanadate-promoted S phase entry.
Zhang Z; Gao N; He H; Huang C; Jiang BH; Jia L; Shi X
Mol Cell Biochem; 2004 Jan; 255(1-2):239-45. PubMed ID: 14971664
[TBL] [Abstract][Full Text] [Related]
60. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect.
Najib S; Sánchez-Margalet V
J Mol Endocrinol; 2001 Aug; 27(1):85-91. PubMed ID: 11463579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
